ABSTRACT
This chapter focuses on innovations in the pharmaceutical industry and its strategic shifts to create long-term value. Its integration of more sustainability-driven frameworks across the value chain yields social, environmental, and firm-level benefits to all stakeholders, from shareholders to consumers. Many pharmaceutical companies have succeeded at establishing, implementing, and monitoring science-based sustainability goals, essentially designing sustainability goals into their business model and management to improve operational and resource efficiency while reducing risk exposure. Bringing the commitments to reality requires further innovation in science and engineering. Notably, green chemistry and sustainable industrial processes improve energy and resource efficiencies and promote sustainable production behaviour. Green chemistry is an interdisciplinary field that encompasses chemistry, chemical engineering, toxicology, and ecology. It involves redesigning toxic molecules, synthetic routes, and industrial processes. Finally, industrial processes must complement corporate strategy and scientific innovations to not only power sustainable behavior across the life cycle of drugs but also scale sustainability.
